Overview
Evolution is inevitable and over a decade there has been magnificent evolution in Human, Machine, Process & regulation to deliver one goal- bring safer and cost-effective drugs to patients. Is PV embarking this journey of evolution to improve patient life by supporting pharmaceutical organizations to be more future ready and breaking boundaries of drug development?
DIA India is thrilled to announce the most awaited Pharmacovigilance Conference in the region - the 9th edition of our Annual Pharmacovigilance Conference Themed Evolving Safety Ecosystem – Pharmacovigilance for tomorrow, to be held on June 2-3, 2022 in an entirely virtual format.
At this 9th Pharmacovigilance Conference DIA brings to you key speakers across the industry sharing insights on the changing PV landscape, expanding the vistas of Drug Safety in the light of Emergency usage of vaccines during pandemic to, ushering in Safe Personalised Medicines through advance Healthcare Science.
Featured
Want to learn more about DIA India 9th Pharmacovigilance Conference: Evolving Safety Ecosystem – Pharmacovigilance for tomorrow? You've come to the right site!
Program Committee
-
Moin Don Adjunct Professor, Jamia Hamdard University, Dept of Pharmacology, School of
Pharmacy, Lead : South Asia Chapter – ISoP, Founder & CEO, PV Consulting, India -
Krishna Bahadursingh Head of Patient Safety
Bristol Myers Squibb, Japan -
Prashant Joshi, RPh Executive Director - Drug Safety
Fortrea, India -
Ritu Jaswal Vice President - Pharmacovigilance Operations
Parexel, India -
Saket Singh Kumar, MSc Principal Director Global PV Capability Lead - Operations
Accenture, India -
J Vijay Venkatraman, MD, MBA Managing Director and CEO
Oviya MedSafe, India -
Vijay Bhargav Vice President, Lifecycle Safety
IQVIA, India
Have an account?